Skip to search formSkip to main contentSkip to account menu

Recombinant Human Adenovirus Type 5 H101

Known as: H101, rAd5 H101 
A replication selective, recombinant, E1B and partial E3 gene deleted form of human adenovirus type 5, with potential antineoplastic activity. Upon… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
The oncolytic viruses now hold a promise of new therapeutic strategy for cancer. Its concept has inspired a wave of commercial… 
Highly Cited
2014
Highly Cited
2014
We report a novel electron-rich molecule based on 3,4-ethylenedioxythiophene (H101). When used as the hole-transporting layer in… 
Review
2007
Review
2007
Since the 1990s, oncolytic viruses were utilized to treat cancer patients from phase I to phase III. Oncolytic virus development… 
Review
2007
Review
2007
The current field of oncolytic virus development has evolved from, and been educated by, the route adenoviruses have taken to… 
Highly Cited
2006
Highly Cited
2006
Oncolytic virus research got a welcome boost last November when Chinese regulators approved the world’s fi rst oncolytic viral… 
Highly Cited
2004
Highly Cited
2004
BACKGROUND & OBJECTIVE H101 is an E1B-55 kDa gene-deleted replication-selective adenovirus, which showed a significant antitumor… 
Highly Cited
2001
Highly Cited
2001
The plasminogen activator, surface protease Pla, of the plague bacterium Yersinia pestis is an important virulence factor that… 
Highly Cited
1994
Highly Cited
1994
Human umbilical vein endothelial cell (HUVEC) senescence in vitro is characterized by the loss of proliferative potential and an…